MollyByrnesHalloranMD

PubMed

• 3 citations
  A Primary Care Provider's Guide to Clinical Needs of Women With Spinal Cord Injury.
  Chloe Slocum, Molly Halloran, Cody Unser> ;Topics in Spinal Cord Injury Rehabilitation. 2020 Jan 1
• 11 citations
  Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.
  Clemens Krepler, Min Xiao, Minu Samanta, Adina Vultur, Hsin-Yi Chen, Patricia Brafford, Patricia Reyes-Uribe, Molly B. Halloran, Thomas C. Chen, Xu He, Denitsa Hristov...> ;Oncotarget. 2016 Sep 17
• 89 citations
  BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
  Tao Wang, Min Xiao, Yingbin Ge, Clemens Krepler, Eric Belser, Alfonso Lopez-Coral, Xaiowei Xu, Gao Zhang, Rikka Azuma, Qin Liu, Rui Liu, Ling Li, Ravi K. Amaravadi, We...> ;Clinical Cancer Research. 2015 Apr 1
• 70 citations
  The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
  Clemens Krepler, Srinivas K. Chunduru, Molly B. Halloran, Xu He, Min Xiao, Adina Vultur, Jessie Villanueva, Yasuhiro Mitsuuchi, Eric M. Neiman, Christopher A. Benetato...> ;Clinical Cancer Research. 2013 Apr 1
• 125 citations
  PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas.
  John T. Lee, Ling Li, Patricia Brafford, Marcia van den Eijnden, Molly B. Halloran, Katrin Sproesser, Nikolas K. Haass, Keiran S.M. Smalley, James Tsai, Gideon Bollag,...> ;Pigment Cell & Melanoma Research. 2010 Dec 1
• Join now to see all